Today: 12 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

IREN stock drops after hours as bitcoin eases and tech pullback cools year-end trade

IREN stock drops after hours as bitcoin eases and tech pullback cools year-end trade

IREN Limited shares dropped 2.3% in after-hours trading Monday, settling at $39.41 after ranging between $38.55 and $42.25. Bitcoin slipped 0.6% to about $87,147, pressuring crypto-linked stocks; Marathon Digital, Riot Platforms, CleanSpark, and Coinbase all fell in late trading. The S&P 500 lost 0.35% and the Nasdaq slid 0.50%. No new company-specific news was reported for IREN.
Goldman Sachs stock drops after hours as year-end pullback hits banks — what investors watch next

Goldman Sachs stock drops after hours as year-end pullback hits banks — what investors watch next

Goldman Sachs shares fell 1.6% to $892.18 in after-hours trading Monday, extending losses from the regular session. U.S. stocks closed lower as Treasury yields slipped, with the Dow down 0.51% and the S&P 500 off 0.35%. Trading volume was light ahead of year-end. The New York Fed reported $25.95 billion drawn from its standing repo facility.
30 December 2025
AST SpaceMobile stock today: ASTS ticks up after hours on AT&T satellite beta update, insider buy filing

AST SpaceMobile stock today: ASTS ticks up after hours on AT&T satellite beta update, insider buy filing

AST SpaceMobile shares closed at $71.47, down 0.7% Monday, then rose about 0.7% after hours. AT&T said it plans a beta satellite-to-cell service in early 2026 and brought a fourth ground gateway online. Director Keith Larson bought 625 shares at $80 last week under a pre-arranged plan, according to an SEC filing. AST reported $1.2 billion in cash at the end of September.
UnitedHealth (UNH) stock slips after hours as UnitedHealthcare delays remote monitoring policy

UnitedHealth (UNH) stock slips after hours as UnitedHealthcare delays remote monitoring policy

UnitedHealth Group shares slipped 0.9% to $328.94 in after-hours trading Monday after its UnitedHealthcare unit postponed a policy tightening reimbursement for remote physiologic monitoring. The move follows scrutiny of remote monitoring costs and billing practices. A federal judge in Idaho also granted UnitedHealthcare a preliminary injunction blocking state enforcement of certain Medicare Advantage marketing rules.
30 December 2025
Intel stock rises after Nvidia closes $5 billion share purchase — what’s next for INTC

Intel stock rises after Nvidia closes $5 billion share purchase — what’s next for INTC

Intel shares rose 1.3% to $36.68 in after-hours trading after the company disclosed it sold 214.8 million new shares to Nvidia for $5 billion in cash. The private placement closed after U.S. antitrust clearance. Nvidia paid $23.28 per share, well below Intel’s current price. Traders are watching for updates on joint chip products and Intel’s next earnings outlook.
CoreWeave stock slips after-hours as year-end trading thins and AI-infra nerves linger

CoreWeave stock slips after-hours as year-end trading thins and AI-infra nerves linger

CoreWeave shares fell 1.9% to $74.92 in after-hours trading Monday, following a volatile session and lighter-than-usual volume. No new company news was reported, with investors watching funding costs, data center buildout execution, and recent insider selling disclosures. The stock traded between $73.03 and $77.75 during the day. The next earnings update is expected in mid-February.
30 December 2025
Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

Eli Lilly shares rose 0.2% to $1,078.73 in after-hours trading Monday, with 1.64 million shares traded. Lilly Endowment Inc. disclosed the sale of 2,629 shares at $1,085.17 each, retaining over 92 million shares. Investors focused on obesity drug pricing, with Lilly and Novo Nordisk preparing pill versions and shifting to telehealth and direct-to-consumer sales. The S&P 500 fell 0.35% and the Nasdaq lost 0.5%.
1 447 448 449 450 451 700

Stock Market Today

  • Zumiez Q4 2025 Revenue Beats Estimates Despite Stock Drop
    March 12, 2026, 5:47 PM EDT. Zumiez (NASDAQ:ZUMZ) reported Q4 CY2025 revenue of $291.3 million, up 4.4% year-on-year and 0.8% above analyst estimates. GAAP EPS rose 8.9% above expectations to $1.16 per share. Adjusted EBITDA reached $37.43 million, a 25.6% beat, driven by strong sales in North America and improved product margins in Europe. Revenue guidance for Q1 CY2026 stands at $191 million, 2.5% higher than forecasts, though EPS guidance of -$0.82 missed estimates by 9.3%. Operating margin expanded to 8.6% from 7.2% the previous year. Zumiez ended the quarter with 716 stores, down from 730 a year earlier, and same-store sales increased 2.2%. CEO Rick Brooks highlighted progress in merchandise and expense management amid ongoing efforts to drive growth and shareholder value.
Go toTop